Bio-View Ltd (TLV:BIOV)
Israel · Delayed Price · Currency is ILS · Price in ILA 5,085.00
+84.00 (1.68%)
Oct 23, 2026, 1:44 PM IDT
Bio-View Market Cap
Bio-View has a market cap or net worth of 6.81 million as of October 23, 2026. It is the 47,751st most valuable company in the world and the 489th biggest in Israel. Its market cap has decreased by 74.32% in one year.
Market Cap
6.81M
Enterprise Value
1.75M
Revenue
20.70M
Global Rank
Country Rank
#489 Israel
PE Ratio
n/a
ChartMarket Cap Chart
Since April 3, 2006, Bio-View's market cap has decreased from 59.79M to 6.81M, a decrease of -88.60%. That is a compound annual growth rate of -10.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 6.81M | -69.55% |
| Dec 31, 2025 | 22.38M | -37.30% |
| Dec 31, 2024 | 35.69M | -21.62% |
| Dec 31, 2023 | 45.53M | -10.12% |
| Dec 29, 2022 | 50.66M | 13.09% |
| Dec 30, 2021 | 44.79M | -20.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Danel (Adir Yeoshua) | 2.68B |
| Amal Holdings A.D. | 2.14B |
| Rafa Laboratories | 1.80B |
| BrainsWay | 1.46B |
| XTL Biopharmaceuticals | 19.87M |
| Can-Fite BioPharma | 18.39M |
| Evogene | 17.92M |
| PsyRX CNS Bio-Tech | 8.19M |